Haemerythrin/HHE cation-binding motif 1
OsHRZ1(AK288394) MATPTPMAGEG--------TLAAVMPRSPSPTASAA----------AGSAAEAPMLIFLYFHKAIRAELEGLHAAAVRLATERAGD---VGALAERCRFFVNIYKHHCDAEDAVIFPALD

OsHRZ2(AK068028) ------------------------------------------------------------------------------------------------------------------------BTS(At3g18290) MATPLPDFETARGGGAVASSSTTVLPSSVSSSSSSSRPLPVANSFSDDAEEISPILIFLFFHKAVCSELEALHRLALEFATGHHVD---LRLLRERYRFLRSIYKHHCNAEDEVIFSALD
At1g74770 MGGGNLHSLPPEN-----------ASVSASYAVTVG----------NTKLSDAPVLFFVYCHKAFRAQLVELRRFATDAAEADSFSGDLAVELSRKFEFLKLVYKYHSAAEDEVIFLALD
At1g18910 MGVGDPLPLPPEKNRREVNKPPDIASTSSSSASAVN----------NARLSDAPILLFVYFHKAFRAQLAELQFLAGDTVRSGS---DLAVELRSKFEFLKLVYKYHSAAEDEVIFSALD
OsHORZ1(Os01g0861700) ------------------------------------------------------------------------------------------------------------------------
At3g54290 ------------------------------------------------------------------------------------------------------------------------
OsHRZ1(AK288394) IRVKNVAGTYSLEHKGENDLFSQLFALLQLDIQNDDSLR---RELASCTGAIQTCLSQHMSKEEEQVFPLLTKKFSYEEQADLVWQFLCNIPVNMMAEFLPWLSSSVSSDEHEDIRSCLC
OsHRZ2(AK068028) ------------------------------------------------------------------------------------------------------------------------BTS(At3g18290) IRVKNVAQTYSLEHKGESNLFDHLFELLNSATETDESYR---RELARSTGALQTSVSQHLAKEQKQVFPLLIEKFKYEEQAYIVWRFLCSIPVNMLAVFLPWISSSISVDESKEMQTCLK
At1g74770 KRVKNIVSNYSLEHAGTDDLFTSIFHWLHVLEEEIGSRSDVLREVILCIGTIQSSICQHMLKEERQVFPLLIEKFSFREQASLVWQFICSVPVMVLEDFLPWMISHLSHEEKIEVENCIK At1g18910 TRVKNIVFNYSLEHDATDDLFTSVFHWLNVLEEEQGNRADVLREVVLCIGTIQSSICQHMLKEERQVFPLMIENFSFEEQASLVWQFICSVPVMVLEEIFPWMTSLLSPKEKSEVETCFK
OsHORZ1(Os01g0861700) ------------------------------------------------------------------------------------------------------------------------
At3g54290 ------------------------------------------------------------------------------------------------------------------------
Haemerythrin/HHE cation-binding motif 2
OsHRZ1(AK288394) KIVPEEKLLQQVVFAWIEGKTTRKVTENSTKSNSEATCDCKDASSIDHADNHISSHEDSKAGNKKYAESIDG--QVERHPIDEILYWHNAIRKELIDIAEETRRMQQSGNFSDISSFNAR
OsHRZ2(AK068028) ------------------------------------------------------------------------------------------------------------------------BTS(At3g18290) KIVPGEKLLQQVIFTWLGGKSNTVASCRIEDSMFQCCLDSSSSMLPCKASREQCACEGSKIGKRKYPELTNFGSSDTLHPVDEIKLWHKSINKEMKEIADEARKIQLSGDFSDLSAFDER
At1g74770 DVAPNEDSLQQVISSWLLDDSQSSCGTPTEIMKGVQYVNVSKSLKKSPESHPSSGCFQRFWEWSKK-SLSIPN--VGRSPIHGLRLFQNAIEKDLRDIQEGLCQAKFQTLILDLDVLMAR At1g18910 EVVPNELSLQLVINSWLIDDSQSSLTALTKIMKGVQSVEVSENMTNSQTNSSSSGVFQRFWQWSKKMSFSSPN--TGHILVHGIHLWHNAIRKDLVDIQKGLCQLTFPSLSLDLNVLVVR
OsHORZ1(Os01g0861700) ------------------------------------------------------------------------------------------------------------------------
At3g54290 ------------------------------------------------------------------------------------------------------------------------
OsHRZ1(AK288394) LQFIADVCIFHSIAEDQVVFPAVDSELSFVHEHAEEERRFN-NFRCLIQQIQIAGAKST-ALDFYSELCSHADQIMETIEKHFCDEETKVLPQARMLFSPEKQRQLLYKSLCVMPLKLLE
OsHRZ2(AK068028) ---------------------------------------------------------------------------MEKIERHFKNEETKVLPQARIHFSSEKQRELLYKSLCVIPLKLLE BTS(At3g18290) LQYIAEVCIFHSLAEDKIIFPAVDGEFSFSEEHDEEENQFN-EFRCLIENIKSAGASSTSAAEFYTKLCSHADQIMETIQRHFHNEEIQVLPLARKNFSFKRQQELLYQSLCIMPLRLIE
At1g74770
LNFLADVLVSYSNAFKKFFHPVLEEMTARR-SSTAKQFNIDDCLENFQRLLYKSADDKTKTDNFLLQLQEELESLIIQVTKQFAIQRTEVFPIISKNCNHEMQKQLLYTSIHVLPLGLLK At1g18910 LNFLADVLIFYSNAFKTFFYPVFEDMVDQQHSSSSKQFTIDGHVENFKKSLD--LETRAGSDNFVITLQEKLESLILTVAKQFSIEETEVFPIISKNCNIEMQRQLLYRSIHFLPLGLLK
OsHORZ1(Os01g0861700) --------------------------------------------------MGNCSPSPRRRGRPTSPSGSPPLDRTPSAKAAGGGATTTVSPYALARSPSVSAAEADGDDGVVRVYGSDG
At3g54290 --------------------------------------------------MGTCFSSSTKSTAEISP--FDLVVKPPPPSAAATAPPTQRIPTAKTETSTVSFTAT------VRLYGPPN
OsHRZ1(AK288394) RVLPWLVSKLSDEEASSFLENMRLAAPSSETALVTLFSGWACKARSEDKSNSGEYLCLTSG-EMRCLLDEVDGLEKCRPFCPCASRSNTDASLHPQTENGSRPGKRGNDAESVPGTNGSD
OsHRZ2(AK068028) RVLPWFVSKLNDQDAEAFLQNMFLAAPSSEAALVTLLSGWACKGRSKGTSNSGKFICLTPR-ALSSPLDE-NGFKDCQ-LCPCS----------LQSDICSRPAKKWNDTESS---NISN BTS(At3g18290) RVLPWLTASLTEDEAKNFLKNLQAGAPKSDVALVTLFSGWACKGRKAGECLSPNGNGLCPV-KTLSNIKEVN-LQSCNACASVPCTSRSTKSCCQHQDK--RPAKR-TAVLSCEKKTTPH At1g74770 CVILWFSAHLSEEESQSILHFLSLEDSSPKKSFPRLLLQWLRFGYSGKTSVERFWKQLDVMFKVRCSCQKEHTEEASGSFSNQT--------------------------------QLQL
At1g18910 CVIMWFSAQLPEDECQSIIHYLSSEDSFPNKPFAHLLLQWFRFGYSGKTPVESFWNELSFMFKPRCSFEEELTEEASGSFFQQS--------------------------------PQKL
OsHORZ1(Os01g0861700) CPVAWRVRVALLYKAAAPVHFTPSEAAPLGRPVLRLSASDPELCGTADELLRHVDARFEGK-----------------------------------------------------------
At3g54290
SLVTSYLRFALLHKKVP-LRFVPSEDQ---KPTIQVGS--ETVSGSREVLLRYIEDKFPEP-----------------------------------------------------------
Haemerythrin/HHE cation-binding motif 3
OsHRZ1 ( 
FKVS-DPY------------SMDPPAGYMNET-PYSSAMNQQILIPGKLRPLLHLPDLFGDKTIGEHLTMDLK-PIDLIFYFHKAMKKDLDYLVRGSARLAT-DYSFLGEFQQRFHLIKF
Supplementary Figure S1 | Amino acid alignment of the haemerythrin domain-containing proteins in rice and Arabidopsis. Domain regions are boxed (orange, haemerythrin/HHE cation-binding motif; yellowish green, CHY-type Zn finger; yellow, CTCHY-type Zn finger; green, RING Zn finger; dark blue, rubredoxin-type fold). Conserved histidine, glutamate, aspartate and cysteine residues that potentially bind to metals are shown in bold and colour.
Haemerythrin/HHE cation-binding motif 3 Table S1 ). (Cont.) or one also containing 100 µM ferric ammonium citrate (++Fe) or ZnSO 4 (++Zn) at the onset of expression induction, purified and subjected to metal concentration measurements. The molar ratios of each metal per protein are shown (means ± s.e.m. of three to nine replicates derived from one to four biological replicates). Asterisks indicate significant differences compared to the Cont. (two-sample Student's t-test; *, P < 0.05; **, P < 0.01; Supplementary Table S1). (d) Ubiquitination assay using anti-MBP antibody. MBP fusions of OsHRZ1ΔH or OsHRZ2ΔH were subjected to in vitro ubiquitination assays with (+) or without (-) ATP, biotinylated ubiquitin (Ub) and human E1 and E2 (UbcH5a). The transcript levels were quantified by RT-PCR in non-transformant (NT), HRZ2i lines 1, 2 and 3 (2i-1, 2i-2 and 2i-3, respectively) and HRZ1i line 1 (1i-1) on day 7 of Fe treatment in hydroponic culture. The expression levels relative to NT under each condition (means ± s.e.m. of three biological replicates after averaging three to four technical replicates for each biological replicate) are shown. Asterisks indicate significant differences for biological replicates compared to the NT (two-sample Student's t-test; *, P < 0.05; **, P < 0.01; Supplementary Table S1). NT, non-transformant; 2i-1, 2i-2 and 2i-3, HRZ2i lines 1, 2 and 3, respectively; 1i-1, HRZ1i line 1; I2pro-IDEF1, IDEF1 induction line 13. The metal concentrations are shown as means ± s.d. of µg/g dry weight (DW) of three to eight replicates derived from three to four biological replicates. Asterisks indicate significant differences compared to NT (two-sample Student's t-test; *, P < 0.05; **, P < 0.01; Supplementary Table S1 ). Normal soil pot exp. Calcareous pot exp. Normal soil pot exp. Calcareous pot exp. . Shown are ratios relative to the NT levels under each condition (means ± s.e.m. of three biological replicates after averaging three to four technical replicates for each biological replicate). Asterisks indicate significant differences for biological replicates compared to NT (two-sample Student's t-test; **, P < 0.01; Supplementary Table S1). 
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OsHORZ1 OsHORZ1 Shown are ratios relative to the WT levels under each condition for OsIRO2, OsNAS2 and OsYSL2. Means ± s.e.m. of three biological replicates for WT, hrz1-1 and hrz2-1 lines, one biological replicate for hrz2-1-HRZ1 line 2 of (a) and two biological replicates for all other lines, after averaging three technical replicates for each biological replicate. Asterisks indicate significant differences for biological replicates compared to WT for OsIRO2, OsNAS2 and OsYSL2 (two-sample Student's t-test; *, P < 0.05; **, P < 0.01; Supplementary Table S1 ). 
